The concomitant inhibition of the PD-L1/PD-1 axis and the direct activation of PD-L1-expressing CAR NK-92 provided a strong anti-tumor effect compared with CAR NK-92 cells alone [179]. The gene discussed is PDCD1; the disease is neoplasm.